Mel Calvert retweeted
📢 A new network will foster collaboration among regulators, industry & researchers to identify regulatory strategies that address the unique challenges of advanced therapies - to ensure patients have timely access to transformative treatments.
birminghambrc.nihr.ac.uk/new…
ALT Picture and quote of Prof Melanie Calvert: "As the number of advanced therapies requiring regulatory approval increases, it is essential that regulatory frameworks are developed that are fit-for-purpose. Our focus at Birmingham is understanding how the patient voice can help shape regulatory decision making...." NIHR Birmingham BRC logo
Mel Calvert retweeted
Patient-reported outcomes are invaluable tools, but may impose a burden on patients; Olalekan Lee Aiyegbusi and colleagues provide a set of 19 recommendations to reduce respondent burden.
#PROs @lee_1881 @drmelcalvert @CPROR_UoB
nature.com/articles/s41591-0…
Mel Calvert retweeted
NEW PUBLICATION!!!! Our team at @CPROR_UoB along with other colleagues have produced a list of recommendations to address respondent burden associated with #PRO assessment.
To read our paper, click on this link --> rdcu.be/dzXrp
⬇️⬇️⬇️ @UoB_IAHR @lee_1881 @drmelcalvert
Mel Calvert retweeted
Well done @KonradMaruszczy !!!! @JPRO_ISOQOL's paper of the year!!! #isoqol #isoqol23 @ISOQOL @CPROR_UoB @drmelcalvert @lee_1881 Tom Keeley @B_Torlinska
Mel Calvert retweeted
6/ At the core of all our work is the aim to improve clinical trials for the benefit of patients. Thanks to our incredible patient partners @ajmk @TO_dpr Richard Stephens & Lesley Roberts for co-designing a dose-finding trial lay summary toolkit with us! tinyurl.com/bdhx7trs
Mel Calvert retweeted
1/ NEW early phase dose-finding reporting guidelines for trial protocols (SPIRIT-DEFINE) and trial reports (CONSORT-DEFINE) to enhance transparency and reproducibility. @bmj_latest
SPIRIT-DEFINE: bmj.com/content/383/bmj-2023…
CONSORT-DEFINE: bmj.com/content/383/bmj-2023…
Mel Calvert retweeted
Delighted to share that our systematic review on the effects of disease modifying therapies in multiple sclerosis has been published👇
@drmelcalvert @lee_1881 @CPROR_UoB
sciencedirect.com/science/ar…
Mel Calvert retweeted
Our patient partners are so talented!
A little overwhelmed when we received this poem from one of our patient partners... #PatientAndPublicInvolvement @LongCOVIDPhysio @LongCovidSOS @LongCovidScot @LongCovid @CPROR_UoB @UoB_IAHR
⤵️⤵️⤵️
Patient and Public Involvement in research is not always easy. But receiving this poem from one of our @tlcstudy #PPI members makes it all worth it!
Thank you all! 🙏
@CPROR_UoB @aparitohealth @drmelcalvert @ShamilHaroon @LongCovid @LongCovidSOS @LongCOVIDPhysio @LongCovidScot
Mel Calvert retweeted
***NEW PUBLICATION*** Development and testing of an #ePRO solution for patients with inflammatory diseases in an early phase trial @CPROR_UoB @UoB_IAHR @UKRI_News @innovateuk #electronicPRO #patientreportedoutcomes
Mel Calvert retweeted
NEW PUBLICATION! @KonradMaruszczy reports results from #qualitative itvs with stakeholders on #PROs providing evidence of longer term tolerability & effectiveness in target population #PatientReportedOutcomes @drmelcalvert @lee_1881 Tom Keeley sciencedirect.com/science/ar…
Mel Calvert retweeted
New Review: Olalekan Lee Aiyegbusi, @drmelcalvert & colleagues (including patient partners) synthesize a checklist of key considerations for conducting patient and public involvement & engagement in research.
#TLCStudy #PPIE #LongCovid@CPROR_UoB @UoB_IAHR
nature.com/articles/s41591-0…
Mel Calvert retweeted
Our @tlcstudy latest paper on Patient & Public Involvement in Health Research has just been published! Huge thanks to our patient partners!
@CPROR_UoB @UoB_IAHR @NatureMedicine @LongCovidSOS @LongCovidScot
To read/download it, please click here ⬇️⬇️⬇️
rdcu.be/dhkO2
Mel Calvert retweeted
Dive into how #PatientReportedOutcomes are a “powerful tool to amplify the patient voice” in clinical care with Dr. Claire Snyder from @hopkinskimmel @JohnsHopkinsSPH and presented at #ASCO23.
@ASCO vjoncology.com/video/bd9uuv0…
Mel Calvert retweeted
Superb networking and exchanging thoughts and new ideas at our @UoB_IAHR Away Day with @KKCheng4 and @terobertsbham #weareIAHR
Mel Calvert retweeted
Are you passionate about promoting equality, diversity and inclusion (#EDI) in research and searching for a new opportunity? We're looking for you!
Apply by 3 July to join our team as an EDI Project Officer and drive EDI initiatives within our BRC: beta.jobs.nhs.uk/candidate/j…
ALT We're hiring! EDI Project Officer, apply by 3 July. Picture of a diverse team.
Mel Calvert retweeted
Please join if you can. Patient generated data to inform the tolerability of drug products… exploring single item overall side effect impact with some fantastic experts in the #PRO field
This Post is from an account that no longer exists. Learn more
Lovely day in Sheffield at #UKPROMS many thanks to the organisers @jillcarton1 @ScHARRSheffield
Mel Calvert retweeted
🎉Congratulations to Prof @Denniston_Ophth on receipt of his prestigious @NIHRresearch Incubator award! 🙌
Prof Denniston will lead an Incubator focused on how #AI & other digital technologies should be regulated for use in #Healthcare
➡️Press release: bit.ly/42zBPvD
ALT Professor Alastair Denniston
Mel Calvert retweeted
*** New publication*** Usability of #ePRO platform with #cancer sufferers➡️huge potential for communicating with clinicians!
Now need to test feasibility in clinic! #patientreportedoutcomes @CPROR_UoB @drmelcalvert @SarahHughesSLT @lee_1881 @UoB_IAHR
cell.com/heliyon/pdf/S2405-8…
Mel Calvert retweeted
BRC researchers working on the @hypermarker project have been awarded a €10m grant from @HorizonEU & @UKRI_News to develop and test AI-based machine learning tools allowing clinicians to personalise treatment for patients with high blood pressure.
birminghambrc.nihr.ac.uk/ai-…